BofA analyst Joanna Gajuk upgraded U.S. Physical Therapy (USPH) to Buy from Neutral with a price target of $115, up from $100. The firm sees a path of recovery from the recent labor pressure and notes that the company is back in the acquisition mode, which BofA calls “an important element of the company’s growth story.” In addition, the firm views U.S. Physical Therapy as relatively less exposed to pos-telection headlines and uncertainty that hospitals will face in 2025, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on USPH:
- U.S. Physical Therapy initiated with an Outperform at JMP Securities
- U.S. Physical Therapy price target raised to $120 from $117 at JPMorgan
- U.S. Physical Therapy acquires eight-clinic hand & physical therapy practice
- U.S. Physical Therapy management to meet with Barrington
- US Physical Therapy Executives to Present at Conferences